umeclidinium (Incruse) as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).
umeclidinium / vilanterol (Anoro) As a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease.
fluticasone furoate / umeclidinium / vilanterol (Trelegy Ellipta) Maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (COPD) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting β2-agonist.
February 2015 decisions news release The Scottish Medicines Consortium (SMC), whose purpose is to review newly licensed medicines, has today published advice that includes four new medicines accepted for use in NHSScotland.
